NCT01174719View on ClinicalTrials.gov

Humanalbumin, Hydroxyethylstarch and Ringer Lactate During Cardiac Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

February 28, 2010

Study Completion Date

April 30, 2010

Conditions
Valvular Heart DiseaseCoronary Artery Disease
Interventions
DRUG

volume replacement

Hydroxyethylstarch up to 50mL/kg/24 hrs

DRUG

Humanalbumin 5%

Humanalbumin 5% up to 50 mL/kg/24 hours

DRUG

volume replacement

up 10 50mL/kg/24 hours

Trial Locations (1)

1090

Vienna General Hospital, Vienna

All Listed Sponsors
lead

Medical University of Vienna

OTHER

NCT01174719 - Humanalbumin, Hydroxyethylstarch and Ringer Lactate During Cardiac Surgery | Biotech Hunter | Biotech Hunter